Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other Working Capital Changes (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Other Working Capital Changes for 8 consecutive years, with -$1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes fell 92.21% to -$1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$552000.0, a 99.06% increase, with the full-year FY2024 number at -$58.9 million, down 5500.38% from a year prior.
  • Other Working Capital Changes was -$1.1 million for Q3 2025 at Precision Biosciences, down from $1.3 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $42.0 million in Q3 2022 to a low of -$57.5 million in Q2 2024.
  • A 5-year average of -$1.8 million and a median of -$500000.0 in 2024 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: soared 827.34% in 2022, then crashed 3212.22% in 2024.
  • Precision Biosciences' Other Working Capital Changes stood at -$2.3 million in 2021, then tumbled by 336.08% to -$9.9 million in 2022, then skyrocketed by 97.9% to -$207000.0 in 2023, then crashed by 141.55% to -$500000.0 in 2024, then crashed by 112.2% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Other Working Capital Changes are -$1.1 million (Q3 2025), $1.3 million (Q2 2025), and -$313000.0 (Q1 2025).